tiprankstipranks
Trending News
More News >
RenovoRx (RNXT)
NASDAQ:RNXT
US Market

RenovoRx (RNXT) Financial Statements

Compare
147 Followers

RenovoRx Financial Overview

RenovoRx's market cap is currently $35.35M. The company's EPS TTM is $-0.08; its P/E ratio is -2.71; RenovoRx is scheduled to report earnings on November 13, 2025, and the estimated EPS forecast is $-0.08. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 43.00K$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 43.00K$ 0.00$ 0.00$ 0.00$ 0.00
Operating Income$ -10.97M$ -11.40M$ -9.95M$ -5.67M$ -3.20M
EBITDA$ -10.97M$ -11.39M$ -9.94M$ -5.48M$ 0.00
Net Income$ -8.81M$ -10.23M$ -9.89M$ -6.32M$ -3.80M
Balance Sheet
Cash & Short-Term Investments$ 7.15M$ 1.17M$ 6.44M$ 15.19M$ 1.79M
Total Assets$ 8.12M$ 1.47M$ 7.26M$ 16.29M$ 1.91M
Total Debt$ 278.00K$ 0.00$ 0.00$ 0.00$ 2.79M
Net Debt$ -6.88M$ -1.17M$ -4.39M$ -15.19M$ 995.00K
Total Liabilities$ 3.64M$ 4.47M$ 1.10M$ 938.00K$ 16.57M
Stockholders' Equity$ 4.48M$ -3.00M$ 6.16M$ 15.35M$ -14.66M
Cash Flow
Free Cash Flow$ -9.14M$ -10.26M$ -8.81M$ -5.93M$ -3.53M
Operating Cash Flow$ -9.13M$ -10.26M$ -8.81M$ -5.92M$ -3.53M
Investing Cash Flow$ -12.00K$ 2.03M$ -2.03M$ -15.00K$ 0.00
Financing Cash Flow$ 15.12M$ 5.01M$ 42.00K$ 19.33M$ 3.20M
Currency in USD

RenovoRx Earnings and Revenue History

RenovoRx Debt to Assets

RenovoRx Cash Flow

RenovoRx Forecast EPS vs Actual EPS